This study analyzes high-engagement social media posts for 3 major drug classes to assess their alignment with Food and Drug Administration and Federal Trade Commission oversight.
No takes yet. Share an insight, caveat, or question.
Kresovich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: